Li Yang
- Rehabilitation top 0.5%
- Wound Healing and Treatments 11
- Molecular Medicine top 2%
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications 13
- Pharmaceutical Science top 2%
- Microbiology top 5%
-
- Allergic Rhinitis and Sensitization 14
- Food Allergy and Anaphylaxis Research 11
-
- RNA Interference and Gene Delivery 13
-
- Cancer Immunotherapy and Biomarkers 11
-
- SARS-CoV-2 and COVID-19 Research 10
-
- Nanoplatforms for cancer theranostics 9
- Co-authors
- Cheng HuYunbing WangLinyu LongQingquan KongDaihua FuYu WangYe WuSiwen Wu
- Journals
- Chemical Engineering Journal (4 papers)Frontiers in Oncology (4 papers)Journal of Controlled Release (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Yang
144 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Rehabilitation 501
- Molecular Medicine 221
- Biomaterials 553
- Pharmaceutical Science 170
- Microbiology 126
Countries citing papers authored by Li Yang
This map shows the geographic impact of Li Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yang more than expected).
Fields of papers citing papers by Li Yang
This network shows the impact of papers produced by Li Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yang. The network helps show where Li Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | Metal-polyphenol nanocomposite hybrid hydrogel: A multifunctional platform for treating diabetic foot ulcers through metabolic microenvironment reprogrammingbreakdown → | 2025 | 27 |
| 7 | 2025 | 4 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 8 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 30 | |
| 13 | 2023 | 20 | |
| 14 | 2022 | 31 | |
| 15 | 2022 | 65 | |
| 16 | Inflammation-Responsive Drug-Loaded Hydrogels with Sequential Hemostasis, Antibacterial, and Anti-Inflammatory Behavior for Chronically Infected Diabetic Wound Treatmentbreakdown → | 2021 | 289 |
| 17 | 2021 | 53 | |
| 18 | 2020 | 1 | |
| 19 | 2019 | 8 | |
| 20 | 1996 | 59 |
About Li Yang
Li Yang is a scholar working on Immunology and Allergy, Rehabilitation, Biomaterials, Biotechnology and Pharmaceutical Science, having authored 164 papers that have together received 2.9k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (14 papers), Electrospun Nanofibers in Biomedical Applications (13 papers), RNA Interference and Gene Delivery (13 papers), Wound Healing and Treatments (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Food Allergy and Anaphylaxis Research (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Rehabilitation (501 citations), Molecular Medicine (221 citations), Biomaterials (553 citations), Pharmaceutical Science (170 citations) and Microbiology (126 citations). Li Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Cheng Hu, Yunbing Wang, Linyu Long, Qingquan Kong, Daihua Fu, Yu Wang, Ye Wu, Siwen Wu, Yuling Yang and Rui Zhang. Their work appears in journals such as Chemical Engineering Journal, Frontiers in Oncology, Journal of Controlled Release, Advanced Science and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.